Atrial fibrillation is one of the most common heart rhythm problems in the world.
It causes the heart to beat irregularly and sometimes very fast, which can lead to symptoms such as palpitations, fatigue, dizziness, and shortness of breath.
More importantly, this condition increases the risk of stroke because blood can pool inside the heart and form clots.
To lower this risk, many patients take anticoagulants, often called blood thinners, which help prevent clots from forming. At the same time, doctors usually prescribe medications to slow the heart rate so the heart can pump more effectively.
Two common medicines used to control heart rate are diltiazem and metoprolol. Both have been widely prescribed for many years and are considered effective for helping the heart beat at a safer pace. Blood thinners such as apixaban and rivaroxaban are also commonly used to prevent strokes in people with atrial fibrillation.
Because these drugs treat different aspects of the condition, patients often take them together. However, a new study from Vanderbilt Health and other researchers suggests that one of these combinations may increase the risk of serious bleeding.
The study analyzed medical records from about 46,000 people with atrial fibrillation who were taking blood thinners along with either diltiazem or metoprolol.
The researchers found that patients who used diltiazem together with apixaban or rivaroxaban were more likely to experience major bleeding compared with those who used metoprolol with the same blood thinners.
Major bleeding can include internal bleeding, bleeding in the brain, or bleeding that requires hospitalization, and it can be life-threatening if not treated quickly.
One reason for this increased risk may be how the body processes medications. Diltiazem affects certain enzymes in the liver that normally help break down drugs. When these enzymes are blocked, blood thinners can stay in the body longer and reach higher levels in the bloodstream.
Higher drug levels can make bleeding more likely. Metoprolol does not appear to interfere with these enzymes in the same way, which may explain why the risk was lower for patients taking that medicine.
The findings are especially important because many people with atrial fibrillation are older and often have other health conditions such as high blood pressure, diabetes, or kidney disease.
These conditions may require multiple medications, increasing the chance of drug interactions. For patients already at high risk of bleeding, even a small increase in risk can have serious consequences.
Doctors emphasize that diltiazem is still an effective treatment for many patients, and not everyone will experience problems.
However, the study highlights the importance of choosing medications carefully and considering safer alternatives when possible. For some patients, especially those taking higher doses or additional interacting drugs, metoprolol may be a better option.
Analyzing the study, the results underscore the need for personalized treatment decisions. What works well for one patient may not be the safest choice for another. Large studies like this help doctors identify hidden risks that may not appear in smaller clinical trials.
Still, the research was based on observational data rather than controlled experiments, so further studies will be needed to confirm the findings and determine which patients are most affected.
Overall, the study serves as a reminder that managing chronic conditions often involves balancing benefits and risks. Patients should never stop or change medications without consulting their healthcare provider, but they may wish to ask their doctors about potential interactions and whether alternative treatments are available.
Better awareness of these risks can help ensure safer care and prevent avoidable complications for people living with atrial fibrillation.
If you care about heart health, please read studies about the best time to take vitamins to prevent heart disease, and calcium supplements could harm your heart health.
For more health information, please see recent studies that blackcurrants can reduce blood sugar after meal and results showing how drinking milk affects risks of heart disease and cancer.
Copyright © 2026 Knowridge Science Report. All rights reserved.
